A Computer-Aided Drug Design Approach to Predict Marine Drug-Like Leads for SARS-CoV-2 Main Protease Inhibition
暂无分享,去创建一个
[1] Susana P. Gaudêncio,et al. Enriching cancer pharmacology with drugs of marine origin , 2020, British journal of pharmacology.
[2] Chris Morley,et al. Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.
[3] M. Middelboe,et al. Marine Viruses: Key Players in Marine Ecosystems , 2017, Viruses.
[4] Sankalp Jain,et al. Comparing the performance of meta-classifiers—a case study on selected imbalanced data sets relevant for prediction of liver toxicity , 2018, Journal of Computer-Aided Molecular Design.
[5] Susana P. Gaudêncio,et al. A Chemoinformatics Approach to the Discovery of Lead-Like Molecules from Marine and Microbial Sources En Route to Antitumor and Antibiotic Drugs , 2014, Marine drugs.
[6] V Kumar,et al. Development of a simple, interpretable and easily transferable QSAR model for quick screening antiviral databases in search of novel 3C-like protease (3CLpro) enzyme inhibitors against SARS-CoV diseases , 2020, SAR and QSAR in environmental research.
[7] Adolfo B Poma,et al. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment , 2020, Journal of biomolecular structure & dynamics.
[8] Joshua S Weitz,et al. Re-examination of the relationship between marine virus and microbial cell abundances , 2016, Nature Microbiology.
[9] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[10] A. N. El-hoshoudy. Investigating the potential antiviral activity drugs against SARS-CoV-2 by molecular docking simulation , 2020, Journal of Molecular Liquids.
[11] Susana P. Gaudêncio,et al. The Madeira Archipelago As a Significant Source of Marine-Derived Actinomycete Diversity with Anticancer and Antimicrobial Potential , 2016, Front. Microbiol..
[12] N. Krstulović,et al. Distribution of marine viruses in the Central and South Adriatic Sea , 2014 .
[13] Douglas E. V. Pires,et al. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures , 2015, Journal of medicinal chemistry.
[14] Robert P. Sheridan,et al. Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling , 2003, J. Chem. Inf. Comput. Sci..
[15] M. Gleeson. Generation of a set of simple, interpretable ADMET rules of thumb. , 2008, Journal of medicinal chemistry.
[16] Shuwen Liu,et al. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19 , 2020, Acta Pharmacologica Sinica.
[17] Susana P. Gaudêncio,et al. Intra‐clade metabolomic profiling of MAR4 Streptomyces from the Macaronesia Atlantic region reveals a source of anti‐biofilm metabolites , 2019, Environmental microbiology.
[18] Florbela Pereira,et al. Computational Methodologies in the Exploration of Marine Natural Product Leads , 2018, Marine drugs.
[19] Susana P. Gaudêncio,et al. In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs , 2018, Biomolecules.
[20] Huan Sun,et al. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease , 2020, Nature Communications.
[21] Susana P. Gaudêncio,et al. Antifouling Napyradiomycins from Marine-Derived Actinomycetes Streptomyces aculeolatus † , 2020, Marine drugs.
[22] Susana P. Gaudêncio,et al. A Computer-Driven Approach to Discover Natural Product Leads for Methicillin-Resistant Staphylococcus aureus Infection Therapy , 2018, Marine drugs.
[23] Florbela Pereira. Have marine natural product drug discovery efforts been productive and how can we improve their efficiency? , 2019, Expert opinion on drug discovery.
[24] R. Awaluddin,et al. Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study , 2020 .
[25] S. Gayen,et al. Chemical-informatics approach to COVID-19 drug discovery: Exploration of important fragments and data mining based prediction of some hits from natural origins as main protease (Mpro) inhibitors , 2020, Journal of Molecular Structure.
[26] S. Ciesek,et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets , 2020, Nature.
[27] Andy Liaw,et al. Classification and Regression by randomForest , 2007 .
[28] CHUN WEI YAP,et al. PaDEL‐descriptor: An open source software to calculate molecular descriptors and fingerprints , 2011, J. Comput. Chem..
[29] A. O. Elzupir. Inhibition of SARS-CoV-2 main protease 3CLpro by means of α-ketoamide and pyridone-containing pharmaceuticals using in silico molecular docking , 2020, Journal of Molecular Structure.
[30] V. Zupo,et al. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms , 2020, Biomolecules.
[31] Vinicius M. Alves,et al. QSAR Modeling of SARS‐CoV Mpro Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2 , 2020, Molecular informatics.
[32] A. Scala,et al. Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study , 2020, Marine drugs.
[33] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[34] Dongqing Wei,et al. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2—a molecular dynamic study , 2020, Journal of biomolecular structure & dynamics.
[35] George Papadatos,et al. The ChEMBL database in 2017 , 2016, Nucleic Acids Res..
[36] C. Maranas,et al. Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity , 2020, Computational and Structural Biotechnology Journal.
[37] Hualiang Jiang,et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors , 2020, Nature.
[38] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[39] D. Blumenthal,et al. Covid-19 - Implications for the Health Care System. , 2020, The New England journal of medicine.